These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Fibroblast growth factor-23, cardiovascular prognosis, and benefit of angiotensin-converting enzyme inhibition in stable ischemic heart disease. Udell JA; Morrow DA; Jarolim P; Sloan S; Hoffman EB; O'Donnell TF; Vora AN; Omland T; Solomon SD; Pfeffer MA; Braunwald E; Sabatine MS J Am Coll Cardiol; 2014 Jun; 63(22):2421-8. PubMed ID: 24727254 [TBL] [Abstract][Full Text] [Related]
4. Decreasing the Risk of Heart Failure in a Changing Post-Myocardial Infarction Environment. Rouleau J N Engl J Med; 2024 Apr; 390(16):1524-1526. PubMed ID: 38587253 [No Abstract] [Full Text] [Related]
5. Safety and costs of initiating angiotensin converting enzyme inhibitors for heart failure in primary care: analysis of individual patient data from studies of left ventricular dysfunction. Mason J; Young P; Freemantle N; Hobbs R BMJ; 2000 Nov; 321(7269):1113-6. PubMed ID: 11061732 [TBL] [Abstract][Full Text] [Related]
6. Real-world algorithms for the optimal use of drugs and devices in the patient post myocardial infarction and the future of post myocardial infarction management. Rudo TJ; Kowey PR Clin Cardiol; 2005 Nov; 28(11 Suppl 1):I58-63. PubMed ID: 16450814 [TBL] [Abstract][Full Text] [Related]
7. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Lancet; 1993 Oct; 342(8875):821-8. PubMed ID: 8104270 [TBL] [Abstract][Full Text] [Related]
8. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico. Lancet; 1994 May; 343(8906):1115-22. PubMed ID: 7910229 [TBL] [Abstract][Full Text] [Related]
9. The TRAndolapril Cardiac Evaluation (TRACE) study: rationale, design, and baseline characteristics of the screened population. The Trace Study Group. Am J Cardiol; 1994 Apr; 73(10):44C-50C. PubMed ID: 8166055 [TBL] [Abstract][Full Text] [Related]
10. The Survival and Ventricular Enlargement (SAVE) study: rationale and perspective. Pfeffer MA Herz; 1993 Dec; 18 Suppl 1():430-5. PubMed ID: 8125423 [TBL] [Abstract][Full Text] [Related]
11. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. Lancet; 1995 Mar; 345(8951):669-85. PubMed ID: 7661937 [TBL] [Abstract][Full Text] [Related]
12. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Pitt B; Segal R; Martinez FA; Meurers G; Cowley AJ; Thomas I; Deedwania PC; Ney DE; Snavely DB; Chang PI Lancet; 1997 Mar; 349(9054):747-52. PubMed ID: 9074572 [TBL] [Abstract][Full Text] [Related]
13. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. Packer M; Bristow MR; Cohn JN; Colucci WS; Fowler MB; Gilbert EM; Shusterman NH N Engl J Med; 1996 May; 334(21):1349-55. PubMed ID: 8614419 [TBL] [Abstract][Full Text] [Related]
14. A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees. Circulation; 1994 Oct; 90(4):1765-73. PubMed ID: 7923660 [TBL] [Abstract][Full Text] [Related]
15. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. Garg R; Yusuf S JAMA; 1995 May; 273(18):1450-6. PubMed ID: 7654275 [TBL] [Abstract][Full Text] [Related]
16. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators. Ambrosioni E; Borghi C; Magnani B N Engl J Med; 1995 Jan; 332(2):80-5. PubMed ID: 7990904 [TBL] [Abstract][Full Text] [Related]
17. Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators. Cleland JG; Erhardt L; Murray G; Hall AS; Ball SG Eur Heart J; 1997 Jan; 18(1):41-51. PubMed ID: 9049514 [TBL] [Abstract][Full Text] [Related]
18. Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group. Circulation; 1998 Jun; 97(22):2202-12. PubMed ID: 9631869 [TBL] [Abstract][Full Text] [Related]
19. Oral captopril versus placebo among 13,634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1). Lancet; 1995 Mar; 345(8951):686-7. PubMed ID: 7885123 [TBL] [Abstract][Full Text] [Related]